pocketful logo light
pocketful logo light
Shree Pacetronix Ltd logo

Shree Pacetronix Ltd

NSE: BSE: 527005

â‚ą184.65

(3.45%)

Fri, 25 Sept 2026, 07:18 pm

mtf coin illustrationMTF 5x

Shree Pacetronix Analysis

dividend

thumbs up icon

Pros

    thumbs up icon

    Cons

    • Unable to evaluate Shree Pacetronix's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
    • Unable to evaluate Shree Pacetronix's dividend against the top 25% market benchmark as the company has not reported any payouts.

    health

    thumbs up icon

    Pros

    • Shree Pacetronix is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
    • Shree Pacetronix is profitable, therefore cash runway is not a concern.
    • Shree Pacetronix is profitable, therefore cash runway is not a concern.
    • Debt is well covered by operating cash flow (42.9%, greater than 20% of total debt).
    • Debt is covered by short term assets, assets are 1.9x debt.
    • Shree Pacetronix's cash and other short term assets cover its long term commitments.
    thumbs up icon

    Cons

    • The level of debt compared to net worth has increased over the past 5 years (47.6% vs 62.6% today).
    • Interest payments on debt are not well covered by earnings (EBIT is 1.4x annual interest expense, ideally 3x coverage).
    • Shree Pacetronix's level of debt (62.6%) compared to net worth is high (greater than 40%).
    • High level of physical assets or inventory.

    management

    thumbs up icon

    Pros

    • Atul's remuneration is lower than average for companies of similar size in India.
    • Atul's compensation has been consistent with company performance over the past year, both up more than 20%.
    thumbs up icon

    Cons

    • The average tenure for the Shree Pacetronix board of directors is less than 3 years, this suggests a new board.
    • The average tenure for the Shree Pacetronix management team is less than 2 years, this suggests a new team.

    misc

    thumbs up icon

    Pros

      thumbs up icon

      Cons

      • Shree Pacetronix is not covered by any analysts.
      • BSE:527005 has not traded for 64 days.

      past

      thumbs up icon

      Pros

      • Shree Pacetronix has delivered over 20% year on year earnings growth in the past 5 years.
      • Shree Pacetronix used its assets more efficiently than the IN Medical Equipment industry average last year based on Return on Assets.
      • Shree Pacetronix has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
      thumbs up icon

      Cons

      • Shree Pacetronix's 1-year earnings growth is less than its 5-year average (20.5% vs 43.7%)
      • Shree Pacetronix has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
      • Shree Pacetronix's earnings growth has not exceeded the IN Medical Equipment industry average in the past year (20.5% vs 21.7%).

      value

      thumbs up icon

      Pros

        thumbs up icon

        Cons

        • Shree Pacetronix's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
        • Shree Pacetronix's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
        • Shree Pacetronix is overvalued based on assets compared to the IN Medical Equipment industry average.
        • Shree Pacetronix is overvalued based on earnings compared to the IN Medical Equipment industry average.
        • Shree Pacetronix is overvalued based on earnings compared to the India market.
        • BSE:527005 is flat (0%) underperforming the Medical Equipment industry which returned 9.6% over the past month.
        • BSE:527005 is flat (0%) underperforming the market in India which returned 8% over the past month.